Angelika Nazarenko

Associate

Washington + 1.202.879.4660

Connect:

Share

Angelika Nazarenko assists clients with tax planning and restructuring and advises on tax consequences in M&A deals. In addition, Angelika has advised clients on tax implications of private and public debt offerings and assisted clients with providing necessary tax-related disclosure in Securities and Exchange Commission (SEC) filings.

Angelika's experience also includes advising clients on application of complex international tax provisions, among which are Foreign Investment in Real Property Tax Act (FIRPTA), branch profits tax, global intangible low-taxed income (GILTI), foreign tax credit, and many others. She approaches every matter with the focus on client service and clients' needs. Angelika has done extensive legal research on the implications of the Tax Cuts and Jobs Act of 2017 as it relates to the participation exemption, section 965 inclusion, GILTI, and many other international tax provisions of the Internal Revenue Code that are affecting and changing business behaviors of corporate and non-corporate participants of the global economy.

Experience

  • Delaware North completes business combination and debt financing transaction of its Illinois Route-Gaming businessJones Day advised Delaware North in the business combination transaction of its route-gaming business in Illinois with Eureka Entertainment's Universal Gaming Group.
  • Bristol Myers Squibb acquires 2seventy bioJones Day is acting as Tax counsel to Bristol Myers Squibb in the $286 million merger with 2seventy bio.
  • Hub Group forms joint venture with EASOJones Day advised Hub Group, Inc. in the formation of a joint venture with Mexico-based EASO.
  • STERIS enters into replacement $1.1 billion revolving credit facilityJones Day represented STERIS plc and its affiliates in connection with a replacement $1.1 billion revolving credit facility with JPMorgan Chase Bank, N.A., as administrative agent.
  • Reneo Pharmaceuticals announces reverse merger with OnKureJones Day represented Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) in an all-stock reverse merger between Reneo and OnKure, Inc., a privately-held, clinical-stage biopharmaceutical company valued at $170 million that is focused on the development of novel precision medicines in oncology.
  • Randstad forms joint venture combining its job board business, Monster, with CareerBuilderJones Day advised Randstad N.V., a multinational publicly traded talent company, in connection with the formation of a joint venture combining its job board business, Monster, with CareerBuilder, a subsidiary of investment funds affiliated with Apollo Global Management, Inc.
  • Five9 acquires AcqueonJones Day advised Five9, Inc. in its acquisition of Acqueon, a pioneering real-time revenue execution platform, realizing Five9's ambition to become the orchestration engine for every interaction across the entire customer journey, including marketing, e-commerce, sales and customer service through AI-driven, omnichannel proactive customer engagement.
  • KKR’s OneStream completes $490 million IPOJones Day represented KKR, as controlling stockholder, in connection with OneStream, Inc.'s $490 million initial public offering and pre-IPO reorganization into an Up-C structure.
  • STERIS sells dental segment to an affiliate of Peak Rock CapitalJones Day advised STERIS Plc in the $787.5 million sale of Dental segment to Peak Rock Capital, a leading middle-market private investment firm.
  • Accurate Background acquires Orange Tree Employment Screening LLCJones Day advised Accurate Background, the largest privately held and minority-owned global provider of compliant background checks, drug and health screening, and workforce monitoring solutions, in its acquisition of Orange Tree Employment Screening, a technology-driven background screening provider.
  • WEG acquires industrial electric motors and generators business from Regal Rexnord CorporationJones Day advised WEG S.A. in the $400 million acquisition of the industrial electric motors and generators business of Regal Rexnord Corporation.
  • AGS Agunsa invests in Omni Transloading & Logistics and Omni Bulk ServicesJones Day advised AGS Agunsa, the North American arm of Agunsa and a key player within the Empresas Navieras Group, in the acquisition of a significant equity interest in Omni Transloading & Logistics and Omni Bulk Services.
  • Five9 raises $747.5 million in Convertible Senior Notes offeringJones Day advised Five9, Inc. in connection with the issuance of $747.5 million of its Convertible Senior Notes due 2029 in a private placement pursuant to Rule 144A.
  • AGS invests in A.R. SAVAGE COMPANYJones Day advised AGS Agunsa, the North American arm of Agunsa and a key player within the Empresas Navieras Group, in the acquisition of a significant equity acquisition in AR SAVAGE COMPANY LLC, along with its associated companies and subsidiaries.
  • Sonoco sells protective solutions packaging business to Black Diamond Capital Management, LLC for $80 millionJones Day advised Sonoco Products Company in the $80 million sale of Sonoco's Protective Solutions assets and business to Black Diamond Capital Management, LLC.
  • PureCycle Technologies completes $250 million Green Convertible Senior Notes offeringJones Day represented PureCycle Technologies, Inc., in connection with a Rule 144A offering of $250 million aggregate principal amount of 7.25% Green Convertible Senior Notes due 2030.
  • Five9 acquires Aceyus for $82 millionJones Day represented Five9, Inc. in its acquisition of 100% of the equity of Aceyus, Inc. for $82 million in cash.
  • Astellas acquires Iveric bioJones Day advised Astellas Pharma Inc. in the $5.9 billion cash acquisition of Iveric bio, Inc., a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
  • ABS sells technical inspection service line to ApaveJones Day advised ABS Group of Companies, Inc. in the sale by one of its subsidiaries, ABSG Consulting, Inc., of its technical inspection service line to Apave Group, an international inspection group.
  • Ansys acquires DiakoptoJones Day advised Ansys in the acquisition of Diakopto, a provider of differentiated EDA solutions to accelerate integrated circuit (IC) development.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.